Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Options for Delivering Isoniazid-Rifapentine (3HP) for TB Prevention: the 3HP Options Implementation Trial

NCT03934931 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT03934931
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03934931 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Options for Delivering Isoniazid-Rifapentine (3HP) for TB Prevention: the 3HP Options Implementation Trial
Lead sponsor
University of California, San Francisco
Phase
Not applicable
Overall status
Completed
Start date
July 13, 2020
Completion date
January 13, 2025
Enrollment
1,656 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv/aids, latent tuberculosis, tuberculosis